Investment platform
Русский
Беларускі
Español
Bluebird
Sell4.97
Spread0.60
Buy5.57

Trade bluebird bio, Inc. - BLUE stock price

Sell4.97
Spread0.60
Buy5.57
1m
5m
15m
30m
1H
4H
1D
1W
History
Open on platform
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic diseases and cancer. Its product candidates include Lenti-D that is in Phase II/III clinical trials for the treatment of cerebral adrenoleukodystrophy, a rare hereditary neurological disorder; and LentiGlobin, which is in various clinical studies for the treatment of transfusion- transfusion-dependent ß-thalassemia and severe sickle cell disease. The company's lead product candidates in oncology include bb2121 and bb21217, which are anti- B-cell maturation antigens in Phase I clinical trials for the treatment of relapsed/refractory multiple myeloma. bluebird bio, Inc. has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. It also has collaborations with Medigene AG for the research and development of T cell receptor product candidates directed against antigens for the treatment of cancer indications; and TC BioPharm Limited to research and develop gamma delta chimeric antigen receptor modified T cell product candidates for cancer immunotherapy, as well as a partnership agreement with Celgene European Investment Company LLC. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Download on the App Store Get it on Google Play None Explore platform Show QR
Articles
Grayscale Investments rebalances Q2 2025 multi-asset funds, adds ONDO, swaps DOT for HBAR
Read more
On-ramping billion users: Stop obsessing over protocols and fix the front door | Opinion
Read more
Story Protocol price breaks out of accumulation range, targets $4
Read more
Sonic crypto battles yearly lows: can price trigger a market reversal?
Read more
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

BLUE price history

  • Last 7 days
  • Last 30 days
  • Last Year
  • Last 2 Years
  • Maximum Period
  • Daily
  • Weekly
  • Monthly
Date Close Change Chg% Open Min. Max.
2022-09-30 4.97 0.00 0.00 4.97 4.97 4.97
2022-09-30 4.97 0.00 0.00 4.97 4.97 4.97
Go help.dzengi.com
Dzengi.com Exchange
Trade BTC & tokenized stocks